Life science tools and diagnostics provider Bio-Techne Corporation has officially opened a state-of-the-art, purpose-built manufacturing facility in Bristol, United Kingdom,…
Read More
Bayer Commits $2.2bn to Establish State-of-the-Art Pharmaceutical Manufacturing Facility at New Albany International Business Park in Ohio
Life sciences giant Bayer has announced a monumental $2.2bn capital investment dedicated to the construction of a cutting-edge pharmaceutical manufacturing…
Read More
Made Scientific Expands US East Coast Footprint with Acquisition of Advanced Pennsylvania Cell Therapy Manufacturing Facility from National Resilience
The landscape of advanced therapeutics manufacturing received a significant boost as Made Scientific officially acquired an expansive 85,000-square-foot cell therapy…
Read More
ABEC Expands US Biomanufacturing Footprint With New Wilson, North Carolina Facility
The global biotechnology and pharmaceutical engineering sector is witnessing a significant infrastructural expansion as ABEC prepares to officially open its…
Read More
FUJIFILM Cellular Dynamics Inaugurates State-of-the-Art Induced Pluripotent Stem Cell Manufacturing Facility in Madison, Wisconsin
FUJIFILM Cellular Dynamics has officially opened its new headquarters and a cutting-edge induced pluripotent stem cell (iPSC) manufacturing facility in…
Read More
Pharma Manufacturing Facility Sales to Outsourcers Signal Growing Industry Demand for Strategic Flexibility
A notable surge in the acquisition of pharmaceutical manufacturing facilities by contract development and manufacturing organizations (CDMOs) has illuminated a…
Read More
Novartis Breaks Ground on New Radioligand Therapy Manufacturing Facility in Denton, Texas, Bolstering US Healthcare Infrastructure
Novartis has commenced construction on a significant new radioligand therapy (RLT) manufacturing facility in Denton, Texas, a pivotal development in…
Read More
Apnimed Secures Up to $150 Million in Credit Facility to Fuel Potential US Launch of Obstructive Sleep Apnea Therapy AD109
Boston, MA – – Apnimed, a clinical-stage biopharmaceutical company focused on developing novel therapies for sleep-related breathing disorders, has announced…
Read More
